Your Best Stock
Markets › Compare › AZN vs LLY

AZN vs LLY

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
AZN · AstraZeneca$165.63 ▲ 1.41%
LLY · Eli Lilly and Co$1,188.19 ▲ 3.23%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

95118140163185Sep 25, '25Mar 25, '26Sep 23, '26
  • AZN +14.9%
  • LLY +64.2%

Head to head

MetricAZNLLY
Price$165.63$1,188.19
Change today▲ 1.41%▲ 3.23%
Market cap$256.87B$1.12T
Return, 3 months-8.9%+6.5%
Return, year to date-8.4%+11.1%
Return, 1 year+11.8%+61.2%
P/E (TTM)24.839.9
P/B5.133.0
P/E percentile vs own 5y13th5th
Dividend yield1.91%0.54%
Revenue growth (YoY, latest qtr)+6.4%+47.7%
Net profit growth (YoY)+2.5%+25.3%
Gross margin81.9%83.4%
Operating margin22.1%49.7%
Net margin17.0%33.5%
Return on equity22.0%102.4%
Analyst target vs. price+32.0%+15.5%
Analyst buy share88%86%
RSI (14)5451
30-day volatility21.5%26.1%
Max drawdown, 1 year-25.3%-23.2%
Trend readLeaning bullishStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • LLY is the largest of the group by market value.
  • LLY has returned the most over the past year.
  • AZN carries the lowest trailing P/E.
  • AZN pays the highest dividend yield.
  • LLY is growing revenue fastest.
  • LLY keeps the most profit per dollar of sales.
  • AZN has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top